NCT06857422

Brief Summary

This randomized controlled trial aims to evaluate the effects of hand fan application on dyspnea, illness perception, anxiety, and depression in COPD patients. A total of 56 voluntary COPD patients (28 experimental, 28 control) will be recruited from Ardahan State Hospital Chest Diseases Clinic. Patients will be randomly assigned to the experimental or control group. The experimental group will receive a hand fan and use it for 10 minutes daily for six weeks, while the control group will receive standard care. Dyspnea, illness perception, anxiety, and depression will be assessed using the Visual Dyspnea Scale, Illness Perception Questionnaire, and Hospital Anxiety and Depression Scale at baseline and after six weeks. Data will be analyzed using statistical software. This study is expected to contribute to the literature by evaluating a non-pharmacological intervention for COPD-related dyspnea and psychological outcomes.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
59

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Feb 2025

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 27, 2025

Completed
1 day until next milestone

Study Start

First participant enrolled

February 28, 2025

Completed
4 days until next milestone

First Posted

Study publicly available on registry

March 4, 2025

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 3, 2025

Completed
11 days until next milestone

Study Completion

Last participant's last visit for all outcomes

September 14, 2025

Completed
Last Updated

September 18, 2025

Status Verified

September 1, 2025

Enrollment Period

6 months

First QC Date

February 27, 2025

Last Update Submit

September 15, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • Dyspnea Severity

    The primary outcome measure of this study will be the severity of dyspnea, assessed using the Visual Analog Scale (VAS). This scale is a subjective tool used to measure the intensity of shortness of breath experienced by participants.

    Pre-intervention: Before the start of the intervention (baseline measurement).Post-intervention: After 6 weeks of intervention (final measurement).

Secondary Outcomes (2)

  • Illness Perception

    Pre-intervention: Before the start of the intervention (baseline measurement).Post-intervention: After 6 weeks of intervention (final measurement).

  • Anxiety and Depression

    Pre-intervention: Before the start of the intervention (baseline measurement).Post-intervention: After 6 weeks of intervention (final measurement).

Study Arms (2)

Experimental group

EXPERIMENTAL

hand fan application

Behavioral: Hand Fan Application

Control group

ACTIVE COMPARATOR

standard care

Other: Standard Care for COPD Patients

Interventions

Participants in the experimental group will be instructed to use a hand fan to cool their face for 10 minutes each day for a period of 6 weeks. The fan should be held approximately 15 cm from the face, focusing on the middle area. This intervention aims to alleviate symptoms of dyspnea and improve psychological well-being, including anxiety, depression, and illness perception. The participants will receive daily reminders to ensure consistent application of the intervention.

Experimental group

Participants in the control group will receive standard care for chronic obstructive pulmonary disease (COPD) patients. This includes routine management and treatment as prescribed by their healthcare providers, such as medication and lifestyle recommendations. They will not be instructed to use a hand fan or any other cooling device during the study period. The control group will continue their regular care without any additional interventions from the research team.

Control group

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Orientation and cooperation
  • No communication problems

You may not qualify if:

  • Having a COPD exacerbation in the last 4 weeks

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Derya ŞİMŞEKLİ

Ardahan, Ardahan, 75000, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Pulmonary Disease, Chronic ObstructiveDyspneaAnxiety DisordersDepression

Interventions

Standard of Care

Condition Hierarchy (Ancestors)

Lung Diseases, ObstructiveLung DiseasesRespiratory Tract DiseasesChronic DiseaseDisease AttributesPathologic ProcessesPathological Conditions, Signs and SymptomsRespiration DisordersSigns and Symptoms, RespiratorySigns and SymptomsMental DisordersBehavioral SymptomsBehavior

Intervention Hierarchy (Ancestors)

Quality Indicators, Health CareQuality of Health CareHealth Services AdministrationHealth Care Quality, Access, and Evaluation

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
Masking Details
Blinding will be done for the researcher, participants and statistician.
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 27, 2025

First Posted

March 4, 2025

Study Start

February 28, 2025

Primary Completion

September 3, 2025

Study Completion

September 14, 2025

Last Updated

September 18, 2025

Record last verified: 2025-09

Locations